BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
CEL-SCI Corp. (NY: CVM)
0.2510 USD  UNCHANGED
Official Closing Price  /  Updated: 6:40 PM EDT, May 23, 2013  /  Add to My Watchlist      
(CVM) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 24, 2013
(Penny Stock DD, 6/22/11)
CEL-SCI Corp. (CVM: News ), Tuesday said an analysis of data from four mid-stage studies to evaluate safety and efficacy of its lead cancer drug Multikine,...(read more)
(Penny Stock DD, 4/27/11)
Rexahn Pharmaceuticals, Inc. (AMEX:RNN) surged by 6.09% to close at $1.22 with overall traded volume of 1.40 million shares in the last trading day. The current market price is 11.43%...(read more)
(Benzinga, 11/1/10)
CEL-SCI Corporation (CVM) announced today that it has received a $733,437 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA). The grant was related to three of the Company's projects, including the Phase III...(read more)
Cel-Sci (CVM) Company Overview

There is no analysis for CVM yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here